Search

everythinglearnresearchcommunity

for

Search:↓

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

The patient responded well to treatment with no disease progression.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

Black women with CCCA are more likely to have uterine fibroids.

Effective alopecia treatment depends on the specific cause and includes medications and procedures.

A young man was diagnosed with a rare hair loss condition usually seen in older women.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

New findings may help diagnose and understand scarring alopecia better.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Trichoscopy is a useful tool for diagnosing patchy hair loss, reducing the need for biopsies.

Most women with long-term, widespread hair loss need a tissue examination for an accurate diagnosis.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Scarring alopecia causes permanent hair loss, and treatment aims to reduce inflammation and stop it from getting worse.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Not all cases with typical signs of Alopecia Areata are actually diagnosed as such.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.